Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

B--To perform the functional characterization of uterine cancer FBXW7 mutations us

Active
HHSN26817HG00040SFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves conducting a detailed functional analysis of FBXW7 mutations associated with uterine cancer by utilizing CRISPR gene-editing technology. The aim is to better understand the role of these specific genetic alterations in cancer development and progression. The project falls under the NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. Issued under solicitation number HHSN26817HG00040S, the contract was posted in September 2017. While specific organizational or agency details, as well as the place of performance, are not provided, the work focuses on advanced molecular biology techniques to provide insights that may inform future therapeutic strategies for uterine cancer. The use of CRISPR technology indicates a cutting-edge approach to this genetic research.

General Info

Functional analysis of FBXW7 uterine cancer mutations using CRISPR for research and therapeutic insights.

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
ContactsNo contacts available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
To perform the functional characterization of uterine cancer FBXW7 mutations using CRISPR technology.

Similar Contracts

Same NAICS industry code

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS